FDA approval for Lilly’s weekly insulin Onswik, shares dipBy Martin Holloway24/09/2026 Onswik FDA approval: Eli Lilly’s once-weekly insulin wins US clearance for type 2 diabetes, but LLY shares slipped on the day.
